Sedlack A, Saleh-Anaraki K, Kumar S, Ear P, Lines K, Roper N
Cancers (Basel). 2022; 14(22).
PMID: 36428741
PMC: 9688518.
DOI: 10.3390/cancers14225646.
Tran C, Borbon L, Mudd J, Abusada E, AghaAmiri S, Ghosh S
Cancers (Basel). 2022; 14(8).
PMID: 35454817
PMC: 9033026.
DOI: 10.3390/cancers14081910.
Drapkin B, Rudin C
Cold Spring Harb Perspect Med. 2020; 11(4).
PMID: 32513672
PMC: 8015694.
DOI: 10.1101/cshperspect.a038240.
Nie H, Rathbun G, Tucker H
J Cell Signal (Los Angel). 2017; 2(3).
PMID: 29177249
PMC: 5699232.
DOI: 10.4172/2576-1471.1000163.
Stovold R, Meredith S, Bryant J, Babur M, Williams K, Dean E
Br J Cancer. 2013; 108(8):1704-11.
PMID: 23519056
PMC: 3668479.
DOI: 10.1038/bjc.2013.112.
Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells.
Kay P, Schlossmacher G, Matthews L, Sommer P, Singh D, White A
PLoS One. 2011; 6(10):e24839.
PMID: 21984896
PMC: 3184945.
DOI: 10.1371/journal.pone.0024839.
Two novel determinants of etoposide resistance in small cell lung cancer.
Lawson M, Cummings N, Rassl D, Russell R, Brenton J, Rintoul R
Cancer Res. 2011; 71(14):4877-87.
PMID: 21642373
PMC: 3145147.
DOI: 10.1158/0008-5472.CAN-11-0080.
Establishment and characterization of primary lung cancer cell lines from Chinese population.
Zheng C, Sun Y, Ye X, Chen H, Ji H
Acta Pharmacol Sin. 2011; 32(3):385-92.
PMID: 21372829
PMC: 4002770.
DOI: 10.1038/aps.2010.214.
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor.
Rice L, Waters C, Eccles J, Garside H, Sommer P, Kay P
J Endocrinol. 2008; 198(3):499-509.
PMID: 18583474
PMC: 2518725.
DOI: 10.1677/JOE-08-0019.
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation.
Berrieman H, Ashman J, Cowen M, Greenman J, Lind M, Cawkwell L
Br J Cancer. 2004; 90(4):900-5.
PMID: 14970871
PMC: 2410166.
DOI: 10.1038/sj.bjc.6601569.
PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
Satchi R, Connors T, Duncan R
Br J Cancer. 2001; 85(7):1070-6.
PMID: 11592781
PMC: 2375098.
DOI: 10.1054/bjoc.2001.2026.
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.
Coulson J, Fiskerstrand C, Woll P, Quinn J
Biochem J. 1999; 344 Pt 3:961-70.
PMID: 10585887
PMC: 1220722.
Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance.
Reeve J, Xiong J, Morgan J, Bleehen N
Br J Cancer. 1996; 73(10):1193-200.
PMID: 8630278
PMC: 2074502.
DOI: 10.1038/bjc.1996.230.
Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.
Heldin N, Usuki K, Bergh J, Westermark B, Heldin C
Br J Cancer. 1993; 68(4):708-11.
PMID: 8398697
PMC: 1968610.
DOI: 10.1038/bjc.1993.414.
Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
Rhodes T, Barrand M, Twentyman P
Br J Cancer. 1994; 70(1):60-6.
PMID: 7912544
PMC: 2033314.
DOI: 10.1038/bjc.1994.250.
The in vitro effects and cross-resistance patterns of some novel anthracyclines.
Twentyman P, Fox N, Wright K, Workman P, Broadhurst M, Martin J
Br J Cancer. 1986; 53(5):585-94.
PMID: 3459509
PMC: 2001391.
DOI: 10.1038/bjc.1986.100.
Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.
Kwok T, Twentyman P
Br J Cancer. 1987; 55(4):367-74.
PMID: 3034319
PMC: 2001700.
DOI: 10.1038/bjc.1987.74.
Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines.
Bepler G, Jaques G, Neumann K, Aumuller G, Gropp C, Havemann K
J Cancer Res Clin Oncol. 1987; 113(1):31-40.
PMID: 3029138
DOI: 10.1007/BF00389964.
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
Twentyman P, Fox N, Wright K, Bleehen N
Br J Cancer. 1986; 53(4):529-37.
PMID: 3011054
PMC: 2001423.
DOI: 10.1038/bjc.1986.83.
Neuron specific enolase expression in carcinoma of the lung.
Reeve J, Stewart J, Watson J, Wulfrank D, Twentyman P, Bleehen N
Br J Cancer. 1986; 53(4):519-28.
PMID: 3011053
PMC: 2001447.
DOI: 10.1038/bjc.1986.82.